October 2024 – Page 22 – Talk Bio

Actionable Insights Powered by AI

AstraZeneca Invests $2 Billion in CSPC’s Lipid-Lowering Therapy

7 months ago talkbio0Tagged AstraZeneca, Cardiovascular Diseases, Dosage Forms, GZMH gene, Investments, Lipid-lowering therapy, Lp(a ) disruptor, Pharmaceutical Group

AstraZeneca, CSPC Pharmaceutical Group, lipid-lowering therapy, Lp(a) disruptor, cardiovascular disease, pharmaceutical investment

European Medicines Agency Investigates Potential Link Between Hair Loss Drugs and Suicidal Thoughts

7 months ago talkbio0Tagged Agencies, European (ethnic group), Feeling suicidal (finding), finasteride, Hair, Multiple Acyl Coenzyme A Dehydrogenase Deficiency, psychiatric side effects

EMA, hair loss drugs, finasteride, dutasteride, suicidal thoughts, psychiatric side effects, European Medicines Agency

Scholar Rock’s Apitegromab Shows Significant Improvement in Spinal Muscular Atrophy Treatment

7 months ago talkbio0Tagged apitegromab, Clinical Trials, GDF8 protein, human, Improvement, Motor function (observable entity), Phase 3, Psychological inhibition, Spinal Muscular Atrophy

Spinal Muscular Atrophy (SMA), Apitegromab, Phase 3 Clinical Trial, Motor Function Improvement, Myostatin Inhibition

Optimizing Expression of Multi-chain and Bispecific Antibodies: Strategies and Considerations

7 months ago talkbio0Tagged Antibodies, Antibodies, Bispecific, Cells, Chinese Hamster Ovary, CHO, Cultured Cell Line, expression vector, Metabolic Engineering, Optimization, production, Recombinants, Stable status

Bispecific Antibodies (bsAbs), Recombinant Antibody Production, Chinese Hamster Ovary (CHO) Cells, Expression Vector Optimization, Metabolic Engineering, Stable Cell Line Development

Siemens Healthineers Secures FDA Approval for Revolutionary 3D Mammography System with 5-Second Acquisition Time

7 months ago talkbio0Tagged 3 Days, Approved, Malignant neoplasm of breast, Mammography, Mammomat B.brilliant, Optical Image Reconstruction, PlatinumTomo, Screening for cancer, Siemens Healthineers, tomosynthesis, UltraHD, United States Food and Drug Administration, wide-angle technology

Siemens Healthineers, FDA approval, 3D mammography, Mammomat B.brilliant, breast cancer screening, wide-angle technology, tomosynthesis, PlatinumTomo, UltraHD image reconstruction.

Baxter’s IV Fluid Production Halted Indefinitely Due to Hurricane Helene Damage

7 months ago talkbio0Tagged Baxter International, healthcare supply chain, Helene, hospital preparedness, Hurricanes, North Carolina factory, shortage

Hurricane Helene, IV fluid shortage, Baxter International, North Carolina factory, healthcare supply chain, hospital preparedness

Johnson & Johnson Halts Phase II Dengue Study Amid Shift in R&D Priorities

7 months ago talkbio0Tagged Antiviral Agents, Communicable Diseases, Dengue Study, Johnson and Johnson, mosnodenvir, Phase II, Priorities, R&D

Johnson & Johnson, Dengue Study, Phase II, Antiviral Drug, Mosnodenvir, Infectious Diseases, R&D Priorities

Lilly’s Obesity Drug Shortage Resolved, Novo’s Continues Amid Industry Efforts to Boost Manufacturing

7 months ago talkbio0Tagged Drug Shortage, Eli, Eli Lilly, Glucagon-Like Peptide 1, Mounjaro, Nordisk, Obesity, pharmaceutical manufacturing, Wegovy, Weight-Loss Agents, Zepbound

Eli Lilly, obesity drug shortage, Mounjaro, Zepbound, Novo Nordisk, Wegovy, GLP-1 drugs, pharmaceutical manufacturing, weight loss drugs.

BIOSECURE Act: A Potential Game-Changer for Biopharma – Industry Implications and Future Directions

7 months ago talkbio0Tagged Biopharma Industry, BIOSECURE, Biotechnology, regulatory, Relations, Supply chain diversification, U.S., U.S.-China

BIOSECURE Act, Biopharma industry, US-China relations, Biotechnology collaborations, Supply chain diversification, Regulatory compliance

GSK, Sanofi, and CSL Secure $72 Million BARDA Funding to Enhance Bird Flu Vaccine Supply

7 months ago talkbio0Tagged BARDA, bird flu vaccine, CSHL1 gene, public health medicine (field), sanofi, SmithKline Beecham, Vaccines

BARDA funding, bird flu vaccine, GSK, Sanofi, CSL, vaccine supply, public health